Rational approach to pharmacologic reduction of cholesterol levels in children

Journal of Pediatrics

Volumn 129, Issue 1, 1996, Pages 4-7

  Sprecher, D L ^a   Daniels, S R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTIPOL; COLESTYRAMINE; LOW DENSITY LIPOPROTEIN;

CHILD; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORONARY RISK; DYSLIPIDEMIA; EDITORIAL; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0029842878     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(96)70183-X     Document Type: Editorial

References (17)

1. National Cholesterol Educational Program Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents Pediatrics 89 suppl 1992 525 584
2. S Tonstad J Knudtzon M Sivertsen H Refsum L Ose Efficacy and safety of cholestyramine in peripubertal and prepubertal children with familial hypercholesterolemia J Pediatr 129 1996 42 49
3. Expert Panel Report on the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Pressure in Adults Arch Intern Med 148 1988 36 69
4. RM Lauer J Lee WR Clarke Factors affecting the relationship between childhood and adult cholesterol levels: the Muscatine study Pediatrics 82 1988 309 318
5. WL Stuhldreher TJ Orchard RP Donahue LH Kuller MR Gloninger AL Drash Cholesterol screening in childhood: the sixteen-year Beaver County lipid study experience J Pediatr 119 1991 551 556
6. American College of Physicians Guidelines for using serum cholesterol, high-density lipoprotein cholesterol and triglyceride levels as screening tests for preventing coronary heart disease in adults Ann Intern Med 124 1996 515 517
7. PM Diller GA Huster AO Leach PM Laskarzewski DL Sprecher Definition and application of the discretionary screening indicators according to the National Cholesterol Education Program for Children and Adolescents J Pediatr 126 1995 345 352
8. The DISC Collaborative Research Group Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol JAMA 273 1995 1429 1435
9. BM Black DL Sprecher Dietary treatment and growth of hyperchylomicronemic children severely restricted in dietary fat Arch Pediatr Adolesc Med [Am J Dis Child] 147 1993 60 62
10. F Lifshitz N Moses Growth failure: a complication of dietary treatment of hypercholesterolemia Arch Pediatr Adolesc Med [Am J Dis Child] 143 1989 537 542
11. EL Mayer DW Jacobsen K Robinson Homocysteine and coronary atherosclerosis J Am Coll Cardiol 27 1996 517 527
12. Lipid Research Clinics Program The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease JAMA 251 1984 351 364
13. DH Blankenhorn SA Nessim RL Johnson ME Sanmarco SP Azen L Cashin-Hemphill Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts JAMA 257 1987 3233 3240
14. L Cashin-Hemphill WJ Mack JM Pogoda ME Sanmarco SP Azen DH Blankenhorn Beneficial effects of colestipol-niacin on coronary atherosclerosis: a 4-year follow-up JAMA 264 1990 3013 3017
15. HR Superko P Greenland RA Manchester NA Andreadis G Schectman NH West Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia Am J Cardiol 70 1992 135 140
16. GR Thompson J Hollyer DD Waters Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart disease Curr Opin Lipidol 5 1995 386 388
17. EA Stein GJ Gormley R Illingworth PO Kwiterovich P Lazkarzewski A one-year placebo-controlled trial of lovastatin in adolescent males with severe FH: lipid and safety chemistry data [Abstract] Circulation 92 1995 1 126